Fierce Biotech March 5, 2024
Haemonetics is dropping at least $160 million to acquire the maker of a system designed to cool down and protect the esophagus from errant damage during cardiac ablation procedures aimed at arrhythmias.
The company said it sees Attune Medical and its ensoETM device as a shortcut for surgeons looking to improve the safety of their treatments for an irregular heartbeat, without them having to buy into the recent rise of pulsed field ablation systems—featuring new hardware that uses electric fields specifically tuned to disrupt certain types of cells over others.
In each case, the goal is to limit the spread of cardiac ablation to nearby tissues; traditional radiofrequency ablation is capable of generating enough heat to injure the adjacent esophagus,...
Today's Sponsors
Today's Sponsor